Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes

Figure 1

Time in range results from intermittent scanning and continuous glucose monitoring after the start of the CFTR modulator therapy (left bar) and after adoption of a low glycaemic index (GI) diet (right bar). The CGM data are summarized as the average of the previous 14 days and categorized as time-in-range based on consensus recommendations. Note that the time spent in “low” and “very low” decreased with the low GI diet, in favour of increase time “in range.”